NCT04776837View on ClinicalTrials.gov

Predicting Disease Progression and/or Recurrence in Cancer

CompletedOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

May 15, 2019

Primary Completion Date

November 19, 2021

Study Completion Date

November 19, 2021

Conditions

Patient Reported Outcome MeasuresColorectal CancerPancreatic CancerBiliary Tract CancerEsophageal CancerMetastatic CancerDisease ProgressionSurvival Analysis

Interventions

BEHAVIORAL

Observational Cohort

Patients will be followed by collecting clinical data, biospecimens, and quality of life assessment

Trial Locations (1)

02115

Massachusetts General Hospital, Boston

All Listed Sponsors

lead

Massachusetts General Hospital

OTHER

NCT04776837 - Predicting Disease Progression and/or Recurrence in Cancer | Biotech Hunter | Biotech Hunter